Ebos Group Ltd Share Price and Fundamentals (EBO)

Overview

EBOS Group Ltd is a major distributor of healthcare, pharmaceutical, medical and animal-care products, with operations spanning Australia, New Zealand and Southeast Asia. At A$15.14, its shares are close to the supplied 52-week low of A$15.00, despite the group’s A$13.5 billion in trailing revenue and reported revenue growth of 7.10%. The investment picture brings together a sizeable, diversified distribution business, a 6.39% dividend yield and a share price sitting below its recent moving averages.

EBOS Group is a large healthcare and animal-care distributor operating across Australia, New Zealand and Southeast Asia. Its healthcare activities span pharmaceutical and medical-product wholesale, logistics, pharmacy management and support services, while its animal-care business supplies products to veterinary clinics, specialist retailers and pet owners. The breadth of these activities gives the group exposure to several parts of the healthcare supply chain as well as pet and veterinary markets. Supplied trailing revenue is A$13.5 billion, with revenue growth of 7.10%.

Key facts

Ticker

EBO

Exchange

AU

ISIN

NZEBOE0001S6

Sector

Healthcare

Industry

Medical Distribution

Country

Australia

Currency

AUD

Price

A$15.14

Previous close

A$15.43

Day change

-A$0.29 (-1.88%)

Market cap

3.1B

52W low

A$15.00

52W high

A$25.45

Price and trend

Price

A$15.14

52W range

A$15.00 – A$25.45

50-day SMA

A$17.30

200-day SMA

A$18.67

Price vs 50D SMA

-12.50%

Price vs 200D SMA

-18.91%

Valuation

P/E

14.02

PEG

4.39

EPS

1.08

Dividend yield

6.39%

Beta

0.15

At A$15.14, EBOS has a market capitalisation of A$3.1 billion and a supplied P/E ratio of about 14.0, alongside a PEG ratio of 4.39. The 6.39% dividend yield may appeal to investors assessing income, but distributions can change. Valuation should be considered alongside the company’s revenue growth, its varied distribution businesses and the subdued share-price position relative to the supplied moving averages. The supplied profit-margin figure of 167% is unusually high and merits caution in interpretation.

Profitability and growth

Revenue growth

7.10%

Revenue TTM

13.5B

Profit margin

167.00%

Analyst view

Comparison uses the last price shown; targets are analyst estimates.

Price

A$15.14

Target price

A$23.19

Target vs last price

53.14% from last price

EBOS combines a sizeable distribution operation with healthcare services and animal-care products, and its reported revenue growth provides evidence of expansion in the supplied period. The share price, however, is near the bottom of its 52-week range and below both the 50-day and 200-day moving averages. A supplied analyst target of A$23.19 is 53.14% from the last price, but this is secondary context and does not establish a likely future outcome.

Risks

EBOS’s broad distribution footprint exposes it to operating and supply-chain pressures across healthcare and animal care, as well as changes in demand and costs in those markets. The share price is close to its 52-week low and sits below both supplied moving averages, indicating weak recent price context. The 6.39% dividend yield is not guaranteed, and the supplied profit-margin figure of 167% is unusually high and should be interpreted cautiously rather than treated as a conventional margin comparison.

FAQ